|
시장보고서
상품코드
1991424
재조합 인자 C 어세이 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Recombinant Factor C Assay Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
재조합 요인 C 어세이 시장 규모는 2025년 2억 937만 달러에서 2034년에는 6억 2,745만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 12.97%로 성장할 것으로 전망됩니다.
내독소 검출을 위한 보다 신뢰할 수 있고 윤리적인 대안을 찾는 산업계의 수요가 증가함에 따라 세계 재조합 인자 C 분석 시장이 확대되고 있습니다. 재조합 인자 C 어세이는 의약품, 의료기기, 생명공학 제품에 함유된 세균성 내독소를 검출하는 데 사용됩니다. 이 분석법은 꽃게의 혈액에 의존하는 기존 검사 방법과 달리 재조합 기술을 사용하여 지속가능하고 일관성 있는 검사 솔루션을 제공합니다. 환경 보호와 윤리적 검사 방식에 대한 관심이 높아지면서 이 기술의 채택을 촉진하고 있습니다.
시장 성장의 주요 요인으로는 제조 공정에서 엄격한 품질 관리를 필요로 하는 제약 및 생명공학 산업이 지속적으로 확대되고 있다는 점을 들 수 있습니다. 규제 당국은 주사제 및 의료기기의 안전성을 확보하기 위해 정확한 내독소 검사를 중요시하고 있습니다. 재조합 인자 C 어세이는 민감도와 재현성이 향상되어 신뢰할 수 있는 검사 솔루션을 원하는 검사실에 점점 더 매력적인 선택이 되고 있습니다.
더 많은 기업들이 지속가능한 테스트 기술로 전환함에 따라 이 시장의 전망은 매우 밝다고 볼 수 있습니다. 재조합 기술 기반 분석에 대한 규제 당국의 수용도가 높아짐에 따라, 제약 제조 시설 전반에서 재조합 기술 기반 분석의 채택이 더욱 확대될 것으로 예상됩니다. 분석 성능의 지속적인 향상과 검사실 자동화를 통해 효율성이 더욱 향상될 수 있습니다. 환경 인식과 제품 안전 기준이 계속 발전함에 따라, 재조합 인자 C 어세이는 업계 전반에 걸쳐 더욱 널리 받아들여질 것입니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 재조합 인자 C 어세이 시장 : 제품 유형별
제5장 세계의 재조합 인자 C 어세이 시장 : 용도별
제6장 세계의 재조합 인자 C 어세이 시장 : 최종사용자별
제7장 세계의 재조합 인자 C 어세이 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.04.14The Recombinant Factor C Assay Market size is expected to reach USD 627.45 Million in 2034 from USD 209.37 Million (2025) growing at a CAGR of 12.97% during 2026-2034.
The global recombinant factor C assay market has expanded as industries seek more reliable and ethical alternatives for endotoxin detection. Recombinant factor C assays are used to detect bacterial endotoxins in pharmaceuticals, medical devices, and biotechnology products. Unlike traditional testing methods that rely on horseshoe crab blood, this assay uses recombinant technology to provide a sustainable and consistent testing solution. Growing concerns about environmental conservation and ethical testing practices have strengthened the adoption of this technology.
Key drivers of market growth include the expanding pharmaceutical and biotechnology industries, which require strict quality control during manufacturing processes. Regulatory authorities emphasize accurate endotoxin testing to ensure the safety of injectable drugs and medical devices. Recombinant factor C assays offer improved sensitivity and reproducibility, making them increasingly attractive to laboratories seeking reliable testing solutions.
The future of this market appears highly positive as more companies transition toward sustainable testing technologies. Increasing regulatory acceptance of recombinant-based assays is expected to encourage broader adoption across pharmaceutical manufacturing facilities. Continuous improvements in assay performance and laboratory automation may further enhance efficiency. As environmental awareness and product safety standards continue to evolve, recombinant factor C assays are likely to gain wider industry acceptance.
MARKET SEGMENTATION
By Product Type
- Kits
- Reagents
- Instruments
By Application
- Endotoxin Testing
- Drug Development
- Vaccine Production
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, Lonza Group AG, WuXi AppTec Co Ltd, Merck KGaA, Charles River Laboratories International Inc, Sartorius AG, Eurofins Scientific, GenScript Biotech Corporation, Agilent Technologies Inc, PerkinElmer Inc, Tecan Group Ltd, BioRad Laboratories Inc, Beckman Coulter Inc, Abcam plc, Hycult Biotech
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Endotoxin Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Vaccine Production Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY END USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End User
- 6.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End User
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End User
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End User
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End User
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End User
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL RECOMBINANT FACTOR C ASSAY INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Thermo Fisher Scientific Inc
- 9.2.2 Lonza Group AG
- 9.2.3 WuXi AppTec Co. Ltd
- 9.2.4 Merck KGaA
- 9.2.5 Charles River Laboratories International Inc
- 9.2.6 Sartorius AG
- 9.2.7 Eurofins Scientific
- 9.2.8 GenScript Biotech Corporation
- 9.2.9 Agilent Technologies Inc
- 9.2.10 PerkinElmer Inc
- 9.2.11 Tecan Group Ltd
- 9.2.12 Bio-Rad Laboratories Inc
- 9.2.13 Beckman Coulter Inc
- 9.2.14 Abcam Plc
- 9.2.15 Hycult Biotech
